Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sight Sciences (SGHT) Invested Capital (2020 - 2025)

Sight Sciences has reported Invested Capital over the past 6 years, most recently at $104.2 million for Q4 2025.

  • Quarterly results put Invested Capital at $104.2 million for Q4 2025, down 17.84% from a year ago — trailing twelve months through Dec 2025 was $104.2 million (down 17.84% YoY), and the annual figure for FY2025 was $104.2 million, down 17.84%.
  • Invested Capital for Q4 2025 was $104.2 million at Sight Sciences, up from $64.3 million in the prior quarter.
  • Over the last five years, Invested Capital for SGHT hit a ceiling of $264.8 million in Q4 2021 and a floor of -$246.0 million in Q3 2021.
  • Median Invested Capital over the past 5 years was $118.0 million (2024), compared with a mean of $94.2 million.
  • Peak annual rise in Invested Capital hit 565.36% in 2021, while the deepest fall reached 207.62% in 2021.
  • Sight Sciences' Invested Capital stood at $264.8 million in 2021, then fell by 26.96% to $193.4 million in 2022, then fell by 20.29% to $154.1 million in 2023, then dropped by 17.69% to $126.9 million in 2024, then dropped by 17.84% to $104.2 million in 2025.
  • The last three reported values for Invested Capital were $104.2 million (Q4 2025), $64.3 million (Q3 2025), and $70.0 million (Q2 2025) per Business Quant data.